Want to join the conversation?
$PDCO's 1Q16 operating expenses increased 22.4% from the previous quarter due to the transaction related costs and Animal Health acquisition. In 1Q16, $PDCO also incurred $9.3MM of transaction costs related to Animal Health acquisition. No outstanding borrowings were reported under the current or previous revolving lines of credit at Aug. 1, 2015.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.